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Arbustini E, Narula N, Tavazzi L, Serio A, Grasso M, Favalli V, Bellazzi R, Tajik JA, Bonow RD,
Fuster V, Narula JThe MOGE(S) Classiﬁcation of Cardiomyopathy for Clinicians.
J Am Coll Cardiol 2014;64:304–18.
Author Robert D. Bonow should have printed as Robert O. Bonow.
The authors apologize for this error.http://dx.doi.org/10.1016/j.jacc.2014.07.015CORRECTION
Holmes Jr DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VYProspective Randomized Evaluation of the Watchman Left Atrial
Appendage Closure Device in Patients With Atrial Fibrillation Versus
Long-Term Warfarin Therapy: The PREVAIL Trial.
J Am Coll Cardiol 2014;64:1–12.
The value for ‘All 7-day procedural complications’ for PREVAIL should have printed as 4.2 not 4.5.
The corrected table is below.TABLE 7 Comparison of Outcomes in Device Patients in PROTECT AF, CAP, and PREVAIL
PROTECT AF CAP PREVAIL p Value
Implant success 90.9 94.3 95.1 0.04
All 7-day procedural complications 8.7 4.2 4.2 0.004
Pericardial effusion requiring surgery 1.6 0.2 0.4 0.03
Pericardial effusion with pericardiocentesis 2.4 1.2 1.5 0.318
Procedure-related strokes 1.1 0.0 0.7 0.02
Device embolization 0.4 0.2 0.7 0.368
Abbreviations as in Tables 3 and 6.We apologize for this error.http://dx.doi.org/10.1016/j.jacc.2014.07.016
